• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国空军服役人员中低风险前列腺癌发病率的增加与治疗方法的选择。

Increasing low risk prostate cancer incidence in United States Air Force servicemen and selection of treatments.

机构信息

Department of Surgery, University of Texas Health Science Center at Houston, Houston, Texas, USA.

出版信息

J Urol. 2011 Jun;185(6):2137-42. doi: 10.1016/j.juro.2011.02.052. Epub 2011 Apr 15.

DOI:10.1016/j.juro.2011.02.052
PMID:21496842
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3171171/
Abstract

PURPOSE

Periodic Health Assessments have been mandated for United States Air Force servicemen since the mid 1990s. Thus, we determined whether United States Air Force prostate cancer incidence rates increased thereafter and how these tumors segregate into low and intermediate/high risk categories. We also identified treatment choices.

MATERIALS AND METHODS

We queried the Department of Defense Automated Central Tumor Registry for prostate cancer diagnosed in United States Air Force servicemen between 1991 and 2008 to determine incidence rates, disease risk category and treatments.

RESULTS

Age adjusted rates in white active duty servicemen diagnosed for the most recent period of 2005 to 2008 increased 3-fold relative to the rate in the earliest period of 1991 to 1994. A similar trend was evident in black servicemen. Relative to the Surveillance, Epidemiology and End Results population prostate cancer rates in active duty United States Air Force men between 1995 and 2008 were significantly increased for the 2 racial groups. A significantly greater proportion of active duty servicemen than retirees (62% vs 40%) presented with low risk disease, defined as prostate specific antigen less than 10 ng/ml, Gleason sum less than 7 and clinical stage T1a-T2a. Of those with low risk disease significantly more active duty servicemen elected curative surgery than retirees (93% vs 53%).

CONCLUSIONS

Prostate cancer incidence rates in United States Air Force servicemen have increased with time, exceeding rates in the Surveillance, Epidemiology and End Results population. While most cases are characterized as low risk, aggressive management is elected.

摘要

目的

自 20 世纪 90 年代中期以来,美国空军的男性军人就被要求进行定期健康评估。因此,我们确定此后美国空军前列腺癌的发病率是否增加,以及这些肿瘤如何分为低危和中高危类别。我们还确定了治疗选择。

材料和方法

我们查询了国防部自动中央肿瘤登记处,以确定在 1991 年至 2008 年期间被诊断为前列腺癌的美国空军男性军人的发病率、疾病风险类别和治疗方法。

结果

与 1991 年至 1994 年的最早时期相比,2005 年至 2008 年期间被诊断为最新时期的白种现役军人的年龄调整发病率增加了 3 倍。黑种军人也有类似的趋势。与监测、流行病学和结果人群相比,1995 年至 2008 年期间美国空军现役男性的前列腺癌发病率在这两个种族群体中均显著增加。与退休军人相比(62%比 40%),现役军人中患有低危疾病(定义为前列腺特异性抗原<10ng/ml、Gleason 总和<7 和临床分期 T1a-T2a)的比例显著更高。在患有低危疾病的现役军人中,选择根治性手术的比例明显高于退休军人(93%比 53%)。

结论

美国空军男性军人的前列腺癌发病率随时间推移而增加,超过了监测、流行病学和结果人群的发病率。虽然大多数病例被认为是低危,但选择了积极的治疗方法。

相似文献

1
Increasing low risk prostate cancer incidence in United States Air Force servicemen and selection of treatments.美国空军服役人员中低风险前列腺癌发病率的增加与治疗方法的选择。
J Urol. 2011 Jun;185(6):2137-42. doi: 10.1016/j.juro.2011.02.052. Epub 2011 Apr 15.
2
Incidence rates of soft tissue sarcoma among U.S. military servicemen: Comparison with the rates in the general U.S. population.美国军人软组织肉瘤的发病率:与美国普通人群发病率的比较。
Cancer. 2025 Jan 1;131(1):e35607. doi: 10.1002/cncr.35607. Epub 2024 Dec 9.
3
Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance.许多前列腺特异性抗原(PSA)筛查检出的前列腺癌的年轻男性可能是主动监测的候选者。
BJU Int. 2013 May;111(6):934-40. doi: 10.1111/j.1464-410X.2012.11768.x. Epub 2013 Jan 25.
4
Racial differences in prostate cancer risk remain among US servicemen with equal access to care.美国军人享有平等的医疗保健机会,但前列腺癌的风险仍存在种族差异。
Prostate. 2010 May 15;70(7):727-34. doi: 10.1002/pros.21105.
5
Incidence rates of bladder and kidney cancers among US military servicemen: comparison with the rates in the general US population.美国军人膀胱癌和肾癌发病率:与美国普通人群发病率比较。
Eur J Cancer Prev. 2024 Nov 1;33(6):505-511. doi: 10.1097/CEJ.0000000000000886. Epub 2024 Mar 22.
6
Incidence Rates of Gynecologic Cancers in the U.S. Active Duty Military Population.美国现役军人中妇科癌症的发病率。
Mil Med. 2020 Sep 18;185(9-10):e1590-e1595. doi: 10.1093/milmed/usaa083.
7
Military occupation and testicular germ cell tumour risk among US Air Force servicemen.美军男性军人职业与睾丸生殖细胞肿瘤风险的相关性。
Occup Environ Med. 2023 Jun;80(6):312-318. doi: 10.1136/oemed-2022-108628. Epub 2023 Mar 27.
8
Trends in testicular germ cell tumors among U.S. military servicemen, 1990-2003.1990 - 2003年美国军人睾丸生殖细胞肿瘤的发病趋势
Mil Med. 2011 Oct;176(10):1184-7. doi: 10.7205/milmed-d-10-00476.
9
Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer.主动监测中危前列腺癌男性患者的趋势。
JAMA Netw Open. 2024 Aug 1;7(8):e2429760. doi: 10.1001/jamanetworkopen.2024.29760.
10
Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.美国转移性前列腺癌的过去、现在和未来发病率及负担。
Eur Urol Focus. 2018 Jan;4(1):121-127. doi: 10.1016/j.euf.2017.10.014. Epub 2017 Nov 20.

本文引用的文献

1
Comprehensive quality-of-life outcomes in the setting of a multidisciplinary, equal access prostate cancer clinic.多学科、平等准入前列腺癌诊所环境中的综合生活质量结果。
Urology. 2010 Nov;76(5):1231-8. doi: 10.1016/j.urology.2010.03.087. Epub 2010 Jun 26.
2
Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database.主动监测候选男性接受根治性前列腺切除术的结果:来自 SEARCH 数据库的结果。
Urology. 2010 Sep;76(3):695-700. doi: 10.1016/j.urology.2009.12.073. Epub 2010 Apr 15.
3
Time trends and local variation in primary treatment of localized prostate cancer.局限性前列腺癌的主要治疗方法的时间趋势和局部变化。
J Clin Oncol. 2010 Mar 1;28(7):1117-23. doi: 10.1200/JCO.2009.26.0133. Epub 2010 Feb 1.
4
Racial differences in prostate cancer risk remain among US servicemen with equal access to care.美国军人享有平等的医疗保健机会,但前列腺癌的风险仍存在种族差异。
Prostate. 2010 May 15;70(7):727-34. doi: 10.1002/pros.21105.
5
Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.局限性前列腺癌大样本主动监测队列长期随访的临床结果。
J Clin Oncol. 2010 Jan 1;28(1):126-31. doi: 10.1200/JCO.2009.24.2180. Epub 2009 Nov 16.
6
Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.前列腺特异性抗原筛查引入后的前列腺癌诊断与治疗:1986 - 2005年
J Natl Cancer Inst. 2009 Oct 7;101(19):1325-9. doi: 10.1093/jnci/djp278. Epub 2009 Aug 31.
7
Cancer incidence in the U.S. military population: comparison with rates from the SEER program.美国军人中的癌症发病率:与监测、流行病学和最终结果(SEER)计划的发病率比较。
Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1740-5. doi: 10.1158/1055-9965.EPI-09-0041.
8
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
9
Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?为什么前列腺癌筛查的高过度诊断概率和长领先时间如此重要?
J Natl Cancer Inst. 2009 Mar 18;101(6):362-3. doi: 10.1093/jnci/djp028. Epub 2009 Mar 10.
10
Prostate cancer: the new landscape.前列腺癌:新态势
Curr Opin Urol. 2009 Mar;19(2):154-60. doi: 10.1097/mou.0b013e328323f5d6.